Patents by Inventor Yoshihiko Minegishi

Yoshihiko Minegishi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230181687
    Abstract: Disclosed herein are methods and compositions for the treatment of age-related dysfunction, particularly, age-related motor impairment.
    Type: Application
    Filed: June 3, 2021
    Publication date: June 15, 2023
    Inventors: Yuji Yamanashi, Ryo Ueta, Satoshi Sugita, Yoshihiko Minegishi
  • Patent number: 11376234
    Abstract: A material which promotes ammonia metabolism in the body, as well as a material which has excellent ammonia metabolism improving effect and is effective for endurance enhancement and anti-fatigue are provided. An ammonia metabolism promoting agent, comprising catechins as an active ingredient. An agent for preventing or ameliorating hyperammonemia, hepatic encephalopathy or chronic fatigue syndrome, comprising catechins compound as an active ingredient. An ammonia metabolism promoting agent, an endurance enhancing agent and an anti-fatigue agent, comprising catechins, citrulline and arginine as active ingredients.
    Type: Grant
    Filed: May 31, 2018
    Date of Patent: July 5, 2022
    Assignee: Kao Corporation
    Inventors: Takahiro Hasumura, Shu Chen, Noriyasu Ota, Mizuki Tsunakawa, Yoshihiko Minegishi
  • Patent number: 11291649
    Abstract: A material which has excellent ammonia metabolism improving effect and is effective for endurance enhancement, anti-fatigue or the like is provided. An ammonia metabolism promoting agent, comprising catechins and ornithine as active ingredients. An endurance enhancing agent, comprising catechins and ornithine as active ingredients. An anti-fatigue agent, comprising catechins and ornithine as active ingredients. An agent for suppressing a reduction in blood glucose level by exercise, comprising catechins and ornithine as active ingredients. An agent for promoting recovery from reduced blood glucose level by exercise, comprising catechins and ornithine as active ingredients. An agent for suppressing a reduction in muscle glycogen by exercise, comprising catechins and ornithine as active ingredients. A muscle endurance enhancing agent, comprising catechins and ornithine as active ingredients.
    Type: Grant
    Filed: May 18, 2018
    Date of Patent: April 5, 2022
    Assignee: Kao Corporation
    Inventors: Takahiro Hasumura, Shu Chen, Noriyasu Ota, Yoshihiko Minegishi, Atsuko Otsuka, Akemi Kobayashi
  • Patent number: 11278586
    Abstract: Provided is a tyrosine formulation excellent in bioabsorbability of tyrosine when ingested orally. An oral formulation with improved bioabsorbability of tyrosine, including glycyltyrosine or a salt thereof or a solvate thereof.
    Type: Grant
    Filed: September 21, 2018
    Date of Patent: March 22, 2022
    Assignee: Kao Corporation
    Inventors: Kotaro Tamura, Masazumi Iwashita, Yoshihiko Minegishi
  • Publication number: 20210228537
    Abstract: A material which promotes ammonia metabolism in the body, as well as a material which has excellent ammonia metabolism improving effect and is effective for endurance enhancement and anti-fatigue are provided. An ammonia metabolism promoting agent, comprising catechins as an active ingredient. An agent for preventing or ameliorating hyperammonemia, hepatic encephalopathy or chronic fatigue syndrome, comprising catechins compound as an active ingredient. An ammonia metabolism promoting agent, an endurance enhancing agent and an anti-fatigue agent, comprising catechins, citrulline and arginine as active ingredients.
    Type: Application
    Filed: May 31, 2018
    Publication date: July 29, 2021
    Applicant: Kao Corporation
    Inventors: Takahiro HASUMURA, Shu CHEN, Noriyasu OTA, Mizuki TSUNAKAWA, Yoshihiko MINEGISHI
  • Publication number: 20200261533
    Abstract: Provided is a tyrosine formulation excellent in bioabsorbability of tyrosine when ingested orally. An oral formulation with improved bioabsorbability of tyrosine, including glycyltyrosine or a salt thereof or a solvate thereof.
    Type: Application
    Filed: September 21, 2018
    Publication date: August 20, 2020
    Applicant: Kao Corporation
    Inventors: Kotaro TAMURA, Masazumi IWASHITA, Yoshihiko MINEGISHI
  • Publication number: 20200197361
    Abstract: A material which has excellent ammonia metabolism improving effect and is effective for endurance enhancement, anti-fatigue or the like is provided. An ammonia metabolism promoting agent, comprising catechins and ornithine as active ingredients. An endurance enhancing agent, comprising catechins and ornithine as active ingredients. An anti-fatigue agent, comprising catechins and ornithine as active ingredients. An agent for suppressing a reduction in blood glucose level by exercise, comprising catechins and ornithine as active ingredients. An agent for promoting recovery from reduced blood glucose level by exercise, comprising catechins and ornithine as active ingredients. An agent for suppressing a reduction in muscle glycogen by exercise, comprising catechins and ornithine as active ingredients. A muscle endurance enhancing agent, comprising catechins and ornithine as active ingredients.
    Type: Application
    Filed: May 18, 2018
    Publication date: June 25, 2020
    Applicant: Kao Corporation
    Inventors: Takahiro HASUMURA, Shu CHEN, Noriyasu OTA, Yoshihiko MINEGISHI, Atsuko OTSUKA, Akemi KOBAYASHI
  • Patent number: 8829057
    Abstract: A method for enhancing endurance and/or for removing fatigue by administering to a subject in need thereof a composition containing an effective amount of nootkatone. The method may be further combined with exercise.
    Type: Grant
    Filed: January 18, 2011
    Date of Patent: September 9, 2014
    Assignee: Kao Corporation
    Inventors: Takatoshi Murase, Yoshihiko Minegishi
  • Publication number: 20120010285
    Abstract: Provision of a pharmaceutical product, a quasi-drug, a food, a beverage, a pet food, a feed, and others which are highly safe, have excellent action of promoting energy consumption, promoting fat burning, promoting carbohydrate burning, or improving an effect of exercise, and which are effective for the prevention or amelioration of obesity or metabolic syndrome or the improvement of motor functions. An agent for promoting energy consumption, an agent for promoting fat burning, an agent for promoting carbohydrate burning, an agent for improving an effect of exercise, an agent for improving motor functions, an agent for inhibiting acetyl-CoA carboxylase 2, and an agent for inhibiting pyruvate dehydrogenase kinase 4 containing chlorogenic acids or salts thereof as an active ingredient.
    Type: Application
    Filed: March 17, 2010
    Publication date: January 12, 2012
    Applicant: KAO CORPORATION
    Inventors: Takatoshi Murase, Koichi Misawa, Yoshihiko Minegishi, Noriyasu Ota, Hideo Ohminami
  • Publication number: 20110118359
    Abstract: A method for enhancing endurance and/or for removing fatigue by administering to a subject in need thereof a composition containing an effective amount of nootkatone. The method may be further combined with exercise.
    Type: Application
    Filed: January 18, 2011
    Publication date: May 19, 2011
    Applicant: Kao Corporation
    Inventors: Takatoshi MURASE, Yoshihiko Minegishi
  • Publication number: 20090162457
    Abstract: To provide an endurance improver, anti-fatigue agent and anti-aging agent having an ingredient taken for long years as a food, having high safety, easily available, and excellent in processability. An endurance improver, anti-fatigue agent, muscle strength improver, motor performance enhancer and anti-aging agent containing resveratrol and/or grape leaf extract as an effective ingredient.
    Type: Application
    Filed: October 25, 2006
    Publication date: June 25, 2009
    Applicant: KAO CORPORATION
    Inventors: Yoshihiko Minegishi, Takatoshi Murase, Satoshi Haramizu
  • Publication number: 20070054965
    Abstract: The present invention relates to provision of AMPK activating agent, endurance enhancing agent, and antifatigue agent, which have rich history of use in foods, high safety, readily available, and high workability, a method of activating AMPK, and a method of preventing, treating and/or ameliorating a life-style-related disease. The present invention provides AMPK activating agent, endurance enhancing agent, and antifatigue agent, each of which contains nootkatone as an active agent. The present invention provides a method of activating AMPK characterized by administering nootkatone in an effective amount, and a method of preventing, treating and/or ameliorating a life-style-related disease characterized by administering nootkatone in an effective amount.
    Type: Application
    Filed: July 5, 2006
    Publication date: March 8, 2007
    Applicant: Kao Corporation
    Inventors: Takatoshi Murase, Yoshihiko Minegishi